Milestone Pharmaceuticals Inc Financial Flexibility Index
Milestone Pharmaceuticals Inc financial flexibility index. Milestone Pharmaceuticals Inc (MIST) has a Financial Flexibility Index of -0.15x as of September 2025. Free cash flow of $-9.81 Million (operating CF $-9.82 Million minus capex $1.98K) represents 0% of total liabilities ($67.25 Million). See MIST free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Milestone Pharmaceuticals Inc (2017–2024)
Financial flexibility index of Milestone Pharmaceuticals Inc from 2017 to 2024. Historical Financial Flexibility Index trend for Milestone Pharmaceuticals Inc across 8 annual periods. Check earnings quality score of Milestone Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
Milestone Pharmaceuticals Inc Financial Flexibility Index by Year (2017–2024)
Milestone Pharmaceuticals Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Milestone Pharmaceuticals Inc. For the full cash flow conversion analysis, see Milestone Pharmaceuticals Inc (MIST) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.46x | $-28.82 Million | $-28.85 Million | $62.35 Million | ▲ +41.7% |
| 2023 | -0.79x | $-46.31 Million | $-46.42 Million | $58.45 Million | ▲ +87.7% |
| 2022 | -6.42x | $-52.20 Million | $-52.47 Million | $8.13 Million | ▼ -40.0% |
| 2021 | -4.58x | $-33.22 Million | $-33.22 Million | $7.25 Million | ▲ +38.0% |
| 2020 | -7.39x | $-50.63 Million | $-50.73 Million | $6.86 Million | ▼ -23.9% |
| 2019 | -5.96x | $-50.74 Million | $-51.15 Million | $8.51 Million | ▼ -3959.9% |
| 2018 | -0.15x | $-21.04 Million | $-21.05 Million | $143.29 Million | ▼ -11.2% |
| 2017 | -0.13x | $-8.02 Million | $-8.05 Million | $60.71 Million | — |